[英文截錄] 益生菌就是對人體有益的微生物, 最常被用於預防及治療各種腸胃的疾病及過敏問題. 最新研究顯示, 益生菌有潛在消炎的能力, 可以降低血清中C-反應蛋白的指數(C-reactive protein), 並在血中白血球單核細胞中, 抑制體內因細菌感染產生的發炎物質(proinflammatory cytokines).
[C-反應蛋白](Source: 台灣健康資訊網)
"原本是當做發炎的指標，當體內有：急性炎症、細菌感染、組織的破壞、惡性腫瘍時，很快就會出現，而治癒時，又很快就消失，就是一種（急性期反應蛋白 acute phase reactant protein）。現在臨床上，C-反應蛋白的檢查，已發展到應用在預測心臟病和腦中風的危險上。"
哎唷喂呀! 專有名詞看得一整個霧沙沙... 簡而言之, 這些我們以為只會治腸胃毛病的益生菌, 對人體的幫助不止在腸胃順暢而已啦!
---------------------------------------------
[研究報告介紹之原文]
Public release date: 20-May-2008
Contact: Jing Zhu
wjg@...
86-105-908-0039
World Journal of Gastroenterology
What else may probiotics do in adults?
Probiotic bacteria, defined as living microorganisms that have
beneficial effects on human health, have mostly been studied in the
prevention and treatment of different gastrointestinal diseases and
allergies. Probiotic products, however, are usually consumed by the
general, healthy population but not much is known what kind of
effects they have on the immune system in healthy adults. It is not
clear how probiotics exert their health effects, but one of the most
probable action mechanisms is the modulation of immune responses via
the gut's mucosal immune system.
The study, performed by the groups of Dr Korpela, Professor Vapaatalo
and Professor Julkunen, will be published on April 7, 2008, in the
World Journal of Gastroenterology.
This study investigated the immunomodulatory effects of probiotics
bacteria in healthy adults. It was found that probiotics have an anti-
inflammatory potential seen as a decrease in serum CRP levels and as
a reduction in bacteria-induced production of proinflammatory
cytokines in peripheral blood mononuclear cells.
Understanding of the specific immunomodulatory effects of probiotics
may help in designing future probiotics for targeted purposes. As the
effects in the present study were investigated in healthy adults, the
real impact of probiotics on inflammatory variables warrants further
evaluation during inflammatory processes and in individuals suffering
from various types of inflammatory or autoimmune diseases.
###
This research was carried out in collaboration with University of
Helsinki (Finland), Valio Research Centre (Finland), and the National
Public Health Institute (Finland). Part of the study was funded by
the Academy of Finland.
Reference: Kekkonen RA, Lummela N, Karjalainen H, Latvala S,
Tynkkynen S, Järvenpää S, Kautiainen H, Julkunen I, Vapaatalo H,
Korpela R. Probiotic intervention has strain-specific anti-
inflammatory effects in healthy adults. World J Gastroenterol 2008; 14
(13): 2029-2036 http://www.wjgnet.com/1007-9327/14/2029.asp
Correspondence to: Riitta Korpela PhD, Assistant Professor,
University of Helsinki, Institute of Biomedicine, Pharmacology, PO
Box 63, 00014 University of Helsinki, Finland.
riitta.korpela@... Telephone: +358-10-3813026 Fax: +358-10-
3813019
About World Journal of Gastroenterology
World Journal of Gastroenterology (WJG), a leading international
journal in gastroenterology and hepatology, has established a
reputation for publishing first class research on esophageal cancer,
gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and
H pylori infection. It provides a forum for both clinicians and
scientists. WJG has been indexed and abstracted in Current
Contents/Clinical Medicine, Science Citation Index Expanded (also
known as SciSearch) and Journal Citation Reports/Science Edition,
Index Medicus, MEDLINE and PubMed, Chemical Abstracts,
EMBASE/Excerpta Medica, Abstracts Journals, Nature Clinical Practice
Gastroenterology and Hepatology, CAB Abstracts and Global Health ISI
JCR 2003-2000 IF: 3.318, 2.532, 1.445 and 0.993. WJG is a weekly
journal published by The WJG Press. The publication dates are the
7th, 14th, 21st, and 28th day of every month. The WJG is supported by
The National Natural Science Foundation of China, No. 30224801 and
No. 30424812. It was founded with the title China National Journal of
New Gastroenterology on October 1, 1995, and renamed WJG on January
25, 1998.
About The WJG Press
The WJG Press mainly publishes World Journal of Gastroenterology.
[C-反應蛋白](Source: 台灣健康資訊網)
"原本是當做發炎的指標，當體內有：急性炎症、細菌感染、組織的破壞、惡性腫瘍時，很快就會出現，而治癒時，又很快就消失，就是一種（急性期反應蛋白 acute phase reactant protein）。現在臨床上，C-反應蛋白的檢查，已發展到應用在預測心臟病和腦中風的危險上。"
哎唷喂呀! 專有名詞看得一整個霧沙沙... 簡而言之, 這些我們以為只會治腸胃毛病的益生菌, 對人體的幫助不止在腸胃順暢而已啦!
---------------------------------------------
[研究報告介紹之原文]
Public release date: 20-May-2008
Contact: Jing Zhu
wjg@...
86-105-908-0039
World Journal of Gastroenterology
What else may probiotics do in adults?
Probiotic bacteria, defined as living microorganisms that have
beneficial effects on human health, have mostly been studied in the
prevention and treatment of different gastrointestinal diseases and
allergies. Probiotic products, however, are usually consumed by the
general, healthy population but not much is known what kind of
effects they have on the immune system in healthy adults. It is not
clear how probiotics exert their health effects, but one of the most
probable action mechanisms is the modulation of immune responses via
the gut's mucosal immune system.
The study, performed by the groups of Dr Korpela, Professor Vapaatalo
and Professor Julkunen, will be published on April 7, 2008, in the
World Journal of Gastroenterology.
This study investigated the immunomodulatory effects of probiotics
bacteria in healthy adults. It was found that probiotics have an anti-
inflammatory potential seen as a decrease in serum CRP levels and as
a reduction in bacteria-induced production of proinflammatory
cytokines in peripheral blood mononuclear cells.
Understanding of the specific immunomodulatory effects of probiotics
may help in designing future probiotics for targeted purposes. As the
effects in the present study were investigated in healthy adults, the
real impact of probiotics on inflammatory variables warrants further
evaluation during inflammatory processes and in individuals suffering
from various types of inflammatory or autoimmune diseases.
###
This research was carried out in collaboration with University of
Helsinki (Finland), Valio Research Centre (Finland), and the National
Public Health Institute (Finland). Part of the study was funded by
the Academy of Finland.
Reference: Kekkonen RA, Lummela N, Karjalainen H, Latvala S,
Tynkkynen S, Järvenpää S, Kautiainen H, Julkunen I, Vapaatalo H,
Korpela R. Probiotic intervention has strain-specific anti-
inflammatory effects in healthy adults. World J Gastroenterol 2008; 14
(13): 2029-2036 http://www.wjgnet.com/1007-9327/14/2029.asp
Correspondence to: Riitta Korpela PhD, Assistant Professor,
University of Helsinki, Institute of Biomedicine, Pharmacology, PO
Box 63, 00014 University of Helsinki, Finland.
riitta.korpela@... Telephone: +358-10-3813026 Fax: +358-10-
3813019
About World Journal of Gastroenterology
World Journal of Gastroenterology (WJG), a leading international
journal in gastroenterology and hepatology, has established a
reputation for publishing first class research on esophageal cancer,
gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and
H pylori infection. It provides a forum for both clinicians and
scientists. WJG has been indexed and abstracted in Current
Contents/Clinical Medicine, Science Citation Index Expanded (also
known as SciSearch) and Journal Citation Reports/Science Edition,
Index Medicus, MEDLINE and PubMed, Chemical Abstracts,
EMBASE/Excerpta Medica, Abstracts Journals, Nature Clinical Practice
Gastroenterology and Hepatology, CAB Abstracts and Global Health ISI
JCR 2003-2000 IF: 3.318, 2.532, 1.445 and 0.993. WJG is a weekly
journal published by The WJG Press. The publication dates are the
7th, 14th, 21st, and 28th day of every month. The WJG is supported by
The National Natural Science Foundation of China, No. 30224801 and
No. 30424812. It was founded with the title China National Journal of
New Gastroenterology on October 1, 1995, and renamed WJG on January
25, 1998.
About The WJG Press
The WJG Press mainly publishes World Journal of Gastroenterology.